MedTrace Logo

Virtual Overdose Response

NCT04391192 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-05-25

No results posted yet for this study

Summary

To help prevent deaths in populations that cannot or will not access physical safer consumption services in Alberta, which may disproportionately include women and those who are not able to self-inject (Potier et al., 2014) the investigators propose to provide virtual (phone-based) supervised consumption services, staffed by people with lived experience.

Conditions

  • Drug Overdose

Interventions

BEHAVIORAL

Virtual Overdose Response

All participants will be provided the phone number and encouraged to call when they use alone.

Sponsors & Collaborators

  • Alberta Innovates Health Solutions

    collaborator OTHER

  • AHS Addiction and Mental Health Strategic Clinical Network

    collaborator UNKNOWN

  • TELUS

    collaborator UNKNOWN

  • AHS Cancer Control Alberta

    lead OTHER

Principal Investigators

  • Katherine Rittenbach, PhD · Alberta Health services

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-30
Primary Completion
2020-10-31
Completion
2021-02-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04391192 on ClinicalTrials.gov